111 related articles for article (PubMed ID: 37838340)
21. Systematic analysis of the prognostic and immunological role of DHX33 in pan-cancer.
Ding J; Zhou J; Shen X; Zhang M; Feng X; Xu Z
Environ Toxicol; 2023 Aug; 38(8):2011-2021. PubMed ID: 37256545
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
Liu Z; Ouyang G; Lu W; Zhang H
Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
[TBL] [Abstract][Full Text] [Related]
23. Loss of the deubiquitinase USP36 destabilizes the RNA helicase DHX33 and causes preimplantation lethality in mice.
Fraile JM; Campos-Iglesias D; Rodríguez F; Astudillo A; Vilarrasa-Blasi R; Verdaguer-Dot N; Prado MA; Paulo JA; Gygi SP; Martín-Subero JI; Freije JMP; López-Otín C
J Biol Chem; 2018 Feb; 293(6):2183-2194. PubMed ID: 29273634
[TBL] [Abstract][Full Text] [Related]
24. DHX33 expression is increased in hepatocellular carcinoma and indicates poor prognosis.
Tian QH; Zhang MF; Luo RG; Fu J; He C; Hu G; Zeng JS
Biochem Biophys Res Commun; 2016 May; 473(4):1163-1169. PubMed ID: 27073163
[TBL] [Abstract][Full Text] [Related]
25. Optimization of a novel potent and selective bacterial DNA helicase inhibitor scaffold from a high throughput screening hit.
Li B; Pai R; Aiello D; Di M; Barnes MH; Peet NP; Bowlin TL; Moir DT
Bioorg Med Chem Lett; 2013 Jun; 23(12):3481-6. PubMed ID: 23664213
[TBL] [Abstract][Full Text] [Related]
26. A high-throughput screen to identify novel small molecule inhibitors of the Werner Syndrome Helicase-Nuclease (WRN).
Sommers JA; Kulikowicz T; Croteau DL; Dexheimer T; Dorjsuren D; Jadhav A; Maloney DJ; Simeonov A; Bohr VA; Brosh RM
PLoS One; 2019; 14(1):e0210525. PubMed ID: 30625228
[TBL] [Abstract][Full Text] [Related]
27. Identification of a selective DDX3X inhibitor with newly developed quantitative high-throughput RNA helicase assays.
Nakao S; Nogami M; Iwatani M; Imaeda T; Ito M; Tanaka T; Tawada M; Endo S; Cary DR; Ohori M; Imaeda Y; Kawamoto T; Aparicio S; Nakanishi A; Araki S
Biochem Biophys Res Commun; 2020 Mar; 523(3):795-801. PubMed ID: 31954521
[TBL] [Abstract][Full Text] [Related]
28. Identification of Novel Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors by Kinase Activity-Based High-Throughput Screening for Anticancer Therapeutics.
Zhang W; Hu X; Chakravarty H; Yang Z; Tam KY
ACS Comb Sci; 2018 Nov; 20(11):660-671. PubMed ID: 30350563
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase.
Yuan X; Yang Q; Liu T; Li K; Liu Y; Zhu C; Zhang Z; Li L; Zhang C; Xie M; Lin J; Zhang J; Jin Y
Eur J Med Chem; 2019 Oct; 179():147-165. PubMed ID: 31252306
[TBL] [Abstract][Full Text] [Related]
30. New fluorescence-based high-throughput screening assay for small molecule inhibitors of tyrosyl-DNA phosphodiesterase 2 (TDP2).
Ribeiro CJA; Kankanala J; Shi K; Kurahashi K; Kiselev E; Ravji A; Pommier Y; Aihara H; Wang Z
Eur J Pharm Sci; 2018 Jun; 118():67-79. PubMed ID: 29574079
[TBL] [Abstract][Full Text] [Related]
31. RNA helicase DHX33 puts a new twist on NLRP3 inflammasome activation.
Brodsky IE
Immunity; 2013 Jul; 39(1):94-6. PubMed ID: 23890068
[TBL] [Abstract][Full Text] [Related]
32. Large-scale High-throughput Screening Revealed 5'-(carbonylamino)-2,3'- bithiophene-4'-carboxylate as Novel Template for Antibacterial Agents.
Ivanenkov YA; Yamidanov RS; Osterman IA; Sergiev PV; Aladinskiy VA; Aladinskaya AV; Terentiev VA; Veselov MS; Ayginin AA; Skvortsov DA; Komarova KS; Zagribelnyy BA; Baimiev AK; Shvetc KY; Baimiev AK; Sofronova AA; Machulkin AE; Petrov RA; Zainullina LF; Maximova MA; Zileeva ZR; Vakhitova YV; Bezrukov DS; Puchinina MM; Dontsova OA
Curr Drug Discov Technol; 2020; 17(5):716-724. PubMed ID: 31161993
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
34. Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay.
Lu T; Hu JC; Lu WC; Han J; Ding H; Jiang H; Zhang YY; Yue LY; Chen SJ; Jiang HL; Chen KX; Chai HF; Luo C
Acta Pharmacol Sin; 2018 Sep; 39(9):1544-1552. PubMed ID: 29795359
[TBL] [Abstract][Full Text] [Related]
35. A small molecule inhibitor of the BLM helicase modulates chromosome stability in human cells.
Nguyen GH; Dexheimer TS; Rosenthal AS; Chu WK; Singh DK; Mosedale G; Bachrati CZ; Schultz L; Sakurai M; Savitsky P; Abu M; McHugh PJ; Bohr VA; Harris CC; Jadhav A; Gileadi O; Maloney DJ; Simeonov A; Hickson ID
Chem Biol; 2013 Jan; 20(1):55-62. PubMed ID: 23352139
[TBL] [Abstract][Full Text] [Related]
36. An Integrated in silico Approach and in vitro Study for the Discovery of Small-Molecule USP7 Inhibitors as Potential Cancer Therapies.
Kanan D; Kanan T; Dogan B; Orhan MD; Avsar T; Durdagi S
ChemMedChem; 2021 Feb; 16(3):555-567. PubMed ID: 33063944
[TBL] [Abstract][Full Text] [Related]
37. Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug.
Mastrangelo E; Pezzullo M; De Burghgraeve T; Kaptein S; Pastorino B; Dallmeier K; de Lamballerie X; Neyts J; Hanson AM; Frick DN; Bolognesi M; Milani M
J Antimicrob Chemother; 2012 Aug; 67(8):1884-94. PubMed ID: 22535622
[TBL] [Abstract][Full Text] [Related]
38. Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.
Johnston PA; Foster CA; Tierno MB; Shun TY; Shinde SN; Paquette WD; Brummond KM; Wipf P; Lazo JS
Assay Drug Dev Technol; 2009 Jun; 7(3):250-65. PubMed ID: 19530895
[TBL] [Abstract][Full Text] [Related]
39. DNA helicases as targets for anti-cancer drugs.
Sharma S; Doherty KM; Brosh RM
Curr Med Chem Anticancer Agents; 2005 May; 5(3):183-99. PubMed ID: 15992349
[TBL] [Abstract][Full Text] [Related]
40. Identification and Analysis of Novel Inhibitors against NS3 Helicase and NS5B RNA-Dependent RNA Polymerase from Hepatitis C Virus 1b (Con1).
Yang N; Sun C; Zhang L; Liu J; Song F
Front Microbiol; 2017; 8():2153. PubMed ID: 29209282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
